| This week's sponsor is Premier Research. | | | Discovering the Great Potential of Immuno-Oncology Drugs
Immuno-modulating agents have been around a long time, but for limited uses. New immuno-oncology pathways promise big advances against a wider range of cancers. Register now for our May 23 webinar. Premier Research. It's what we do. Best. |
Featured Story | Monday, May 1, 2017 A phase 2 trial of Neurotrope’s Alzheimer’s disease candidate has missed its primary endpoint. The study set out to show bryostatin improved performance on a neuropsychological test but failed to achieve statistical significance over placebo. |
|
|
| This week's sponsor is Sensors Expo & Conference 2017. | | | |
Top Stories | Monday, May 1, 2017 Robert Plenge is to take the plunge and leave his role at Merck as VP and head of translational medicine to take up a new position at Celgene to run its immunology R&D. |
|
|
| Monday, May 1, 2017 President Donald Trump's push for a reduction in the NIH budget came to nothing last night, after Congress agreed instead to increase it by $2 billion for the second year in a row. |
|
|
Monday, April 24, 2017 It’s a critical tradeoff for life. Our bodies use sugar and fat from the food we consume to produce energy in our cells’ mitochondria, the internal powerhouses that give us the energy we need for all our vital functions. | Monday, May 1, 2017 Atlantic Healthcare has started a rolling submission for its antisense drug alicaforsen enema. The transatlantic pharma company got the process going by filing its nonclinical package with the FDA, positioning it to hit the ground running if its phase 3 trial in a rare form of inflammatory bowel disease delivers positive data. |
|
|
| Monday, May 1, 2017 Shire will pay $20 million upfront, with a potential $535 million biobucks if all goes according to plan, for Parion Sciences’ dry eye candidate P-321 as it looks to boost its ophthalmology pipeline. |
|
|
| Monday, May 1, 2017 Amalgam Rx, a new company focusing on digital therapies for chronic diseases, launched Monday with the first FDA-cleared mobile app that automates the titration—or dose—of basal insulin for patients with Type 2 diabetes. |
|
|
| Friday, April 28, 2017 Every cell in the body has its own power source in the form of mitochondria, and those energy producers have their own DNA. Scientists led by the University of Sheffield have identified one of the enzymes that’s crucial to repairing damaged mitochondrial DNA—a finding they believe will enhance the search for effective cancer drugs and treatments for other diseases. |
|
|
| Monday, May 1, 2017 With demand for GlaxoSmithKline’s lupus-fighter Benlysta growing in the U.S. and approval of a new formulation expected later this year, the U.K. drugmaker says it is time to bring on more capacity at a U.S. manufacturing facility. |
|
|
| Monday, May 1, 2017 The editors and reporters of FiercePharmaMarketing got together to select our top DTC ad picks for the year. Some impressed us with creativity, while others broke new ground or proved particularly effective. |
|
|
| This week's sponsor is J.P. Morgan Private Bank. | | | How Pre-Transaction Planning Can Maximize Your Wealth
You've worked hard to build a successful healthcare business. To reap the rewards of a sale, merger, recap or IPO, be sure you maximize the value of your equity interests with careful pre-transaction planning. Learn how J.P. Morgan Private Bank can help you protect your wealth. Read the article. |
| | | Aeterna Zentaris shares dropped by 60% after the failure of its phase 3 candidate Zoptrex (zoptarelin doxorubicin) in endometrial cancer patients. Release Alkermes has completed patient enrollment in the first of its two key phase 3 tests for ALKS 3831, its once-daily, oral atypical antipsychotic candidate for schizophrenia patients. Statement Chan Zuckerberg Biohub gains former CEO of Fluidigm, Gajus Worthington, as its new COO. Release | |
|
Resources Sponsored By Reprints Desk Puzzled by Scientific Literature Access? Here is your guide for navigating knowledge management’s twists and turns! If yours is a small- or medium-sized biopharma business, we can help you putting the pieces together. Learn the secrets of top knowledge management experts who will show you how to search, discover, acquire and manage knowledge in new ways. Presented By: Covance The recent evolution of immunotherapies and their potential applications have greatly impacted patients’ options for effective oncology treatments. These advances have been powered in part by the use of biomarkers, companion diagnostics (CDx) and complementary diagnostics. Read the white paper. Sponsored By: DocuSign DocuSign’s eSignature solutions modernize healthcare and life science organizations by eliminating paper and antiquated signature processes while meeting compliance requirements and reducing costs and errors. Sponsored By: DocuSign The patients who rely on your scientific leadership are expecting more. Sponsored By: DocuSign The U.S. Department of Justice has collected upwards of $17 billion in settlements from the healthcare industry since 2009, including more than $2 billion from a single life sciences company. 2017 BIO International Convention: The Largest Global Biotech Partnering Event of the Year June 19-22 | San Diego, CA World Preclinical Congress June 12-16, 2017 | Boston, MA Drug Development Boot Camp® 2017 November 15-16, 2017 | Boston, MA Medical Sensors Design Conference May 8-9, 2017 │ Boston Marriott Newton │ Newton, MA Chief Medical Officer Summit in Emerging Biotechs 5th Annual May 10-11, 2017 | Boston, MA MIXiii-BIOMED 2017 May 23-25, 2017 | Tel Aviv, Israel FierceBiotech Executive Breakfast- Tackling the Drug Price Problem: A Town Hall Debate June 21, 2017 | San Diego, CA 8th Transparency and Aggregate Spend West May 23-24, 2017 | San Diego, CA |
